SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CNSI Cambridge Neuroscience
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Miljenko Zuanic who wrote (58)1/8/1997 9:48:00 PM
From: James Silverman   of 675
 
I take it the offer is set for tomorrow.
Although I do not own shares in CNSI, I would have no problem with such an offer either way. Its only two million shares and as you know biotechs burn through cash like a cat eats tunafish. I imagine they figure they will need some cash to see Cerestat through and assuming its approved their would be no further need for dilution. As a shareholder this scenario would be most appealing.

You sound like a technical trader-in that case the overhang of a couple million shares would alter the equation. Although on the flip side when these offerings take place- usually shortly afterwards the slew of analyst recommendations come forth which will certainly help.
LT the fate of Cerestat remains the integral factor.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News